The BBC has reported this week that senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are contributing to up to half of patients not getting the right treatment for some cancers.
Putting lives at risk
The National Cancer Audit Collaborating Centre (NatCan) has provided evidence to the BBC which highlights particular problems with prostate, kidney, and colon cancers.
It carries out audits across nine major cancers, those responsible for 80% of cases, and found shortfalls across a range of different cancer types and stages.
The group said it had found significant variation between hospitals and warned that problems accessing nationally-recommended treatments were putting lives at risk.
The figures found by NatCan show:
- 50% of stage four renal cell carcinoma patients do not get drug treatment.
- 35% of stage three colon cancer cases do not get chemotherapy within three months of surgery, and at some hospitals, the numbers exceed 60%.
- 30% of patients with high-risk prostate cancer do not get curative treatment with either surgery or radiotherapy.
NatCan highlighted that some of these patients would be choosing not to have treatment, and some may not be well enough to undergo treatment. However, they said that this does not fully explain the scale of the shortfall or variation between hospitals.
Doing better could extend and save lives
Clinical Director of NatCan, Professor Ajay Aggarwal, said it was concerning so many patients were not getting the recommended treatment.
He said:
“We need to do better. With cancer, we often hear people talking about what the next breakthrough is but, the fact remains, using what we have better could make a huge difference. It would extend and save lives.”
President of the Royal College of Surgeons, Tim Mitchell, shared the same concerns. He said:
“The NHS has access to world-class cancer treatments and care, but inconsistent delivery means far too many patients miss out. At worst, this may mean some patients are needlessly dying or in unnecessary pain.”
Cancer strategy
The Government says improving services is a key priority and England is in the process of drawing up a new cancer strategy.
Ministers say it will revolutionise services.
Eve Byrne from Macmillan Cancer Support said the NatCan findings were “quite staggering” and believes that tackling the variation should be the first priority of the national cancer strategy.
She said:
“Getting the best care to give you the greatest chance of survival should not come down to which hospital you attend or where you live in the country. We are concerned that people from deprived, rural, or ethnically diverse communities could be losing out in particular.”
NHS England cancer director, Professor Peter Johnson, said:
“We know that patients’ experience of cancer treatment does vary – and we are working hard to address this.”
A new cancer strategy is expected to be published in the second half of the year.
A spokesperson for the Department of Health and Social Care said:
“Patients should be able to access the cancer care they need regardless of where they live, and we are committed to addressing health inequalities as we rebuild the NHS.”
Comment
What feels a lot like a postcode lottery of cancer care cannot be acceptable, especially when prompt diagnosis and treatment are so vital in the fight against cancer.
The figures show that there is clear variance and failings in cancer care which is putting lives at risk. Action absolutely must be taken, and this must be given priority by the Government in its plans for cancer care going forward.
How can we help?
Danielle Young is a Legal Director in our Medical Negligence team, which has been ranked in tier one by the independently researched publication, The Legal 500.
If you have any questions in relation to the subjects discussed in this article, then please get in touch with Danielle or another member of the team in Derby, Leicester, or Nottingham on 0800 024 1976 or via our online form.
Contact us